NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Assuming that is true, it still only explains the lack of transparency by the regulator through May 9, 2022.

Bureaucratic nonsense could be a partial explanation for the time since May 10, 2022. Maybe there was no mechanism for properly informing the company of the reason once the trial ended and NWBO perhaps had strategic in curiosity and never asked the regulator after TLD and so was never told. This they could always say they didn’t know and the company cannot share what it does not know.

Or maybe NWBO did find out the reason from the regulator after TLD and chose not to share it.

As with most things NWBO there will be different ‘obvious’ answers and little clarity.